Organogenesis Holdings Inc
ORGO4.686USD
+0.176+3.90%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
594.44MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Organogenesis Holdings Inc Unternehmen
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.
Unternehmensinformationen
BörsenkürzelORGO
Name des UnternehmensOrganogenesis Holdings Inc
IPO-datumDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Anzahl der mitarbeiter869
WertpapierartOrdinary Share
GeschäftsjahresendeDec 02
Addresse85 Dan Rd
StadtCANTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl02021-2810
Telefon17815750775
Websitehttps://investors.organogenesis.com
BörsenkürzelORGO
IPO-datumDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
200.53K
-20.89%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Mr. Arthur S. Leibowitz, CPA
Mr. Arthur S. Leibowitz, CPA
Lead Independent Director
Lead Independent Director
187.61K
+0.78%
Ms. Prathyusha Duraibabu, CPA
Ms. Prathyusha Duraibabu, CPA
Independent Director
Independent Director
148.64K
+3.64%
Mr. Jon L. Giacomin
Mr. Jon L. Giacomin
Independent Director
Independent Director
142.62K
+2.31%
Dr. Gilberto Quintero, Ph.D.
Dr. Gilberto Quintero, Ph.D.
Independent Director
Independent Director
140.67K
+1.04%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
200.53K
-20.89%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Advanced Wound Care
79.93M
92.20%
Surgical & Sports Medicine
6.77M
7.80%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Advanced Wound Care
79.93M
92.20%
Surgical & Sports Medicine
6.77M
7.80%
Aktionärsstatistik
Aktualisiert: Sat, Jul 12
Aktualisiert: Sat, Jul 12
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
9.84%
Morgan Stanley & Co. LLC
9.49%
Nussdorf (Glenn H)
9.39%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.55%
Aktionäre
Aktionäre
Anteil
Soleus Capital Management, L.P.
9.84%
Morgan Stanley & Co. LLC
9.49%
Nussdorf (Glenn H)
9.39%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.55%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
32.52%
Investment Advisor
16.60%
Corporation
14.12%
Investment Advisor/Hedge Fund
13.05%
Hedge Fund
12.78%
Research Firm
10.83%
Sovereign Wealth Fund
0.38%
Pension Fund
0.36%
Bank and Trust
0.06%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
301
127.82M
100.77%
+5.72M
2025Q1
324
125.21M
99.06%
+1.00M
2024Q4
344
121.01M
95.72%
-4.65M
2024Q3
354
109.09M
82.30%
-7.23M
2024Q2
369
107.79M
81.32%
-6.45M
2024Q1
374
102.47M
77.65%
-12.90M
2023Q4
378
102.14M
77.80%
-10.89M
2023Q3
390
113.75M
86.92%
-11.36M
2023Q2
400
112.98M
86.34%
-14.25M
2023Q1
400
117.68M
90.49%
-17.51M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Soleus Capital Management, L.P.
12.48M
9.84%
-6.53K
-0.05%
Mar 31, 2025
Morgan Stanley & Co. LLC
12.03M
9.49%
+286.33K
+2.44%
Mar 31, 2025
Nussdorf (Glenn H)
11.91M
9.39%
--
--
Jun 24, 2025
Ades (Alan A)
11.19M
8.82%
--
--
Jun 24, 2025
Erani (Dennis)
10.04M
7.92%
--
--
Jun 24, 2025
Organo PFG LLC
8.28M
6.53%
--
--
Jun 24, 2025
RED Holdings, L.L.C.
6.78M
5.35%
--
--
Jun 24, 2025
BlackRock Institutional Trust Company, N.A.
4.54M
3.58%
-205.40K
-4.33%
Mar 31, 2025
The Vanguard Group, Inc.
4.43M
3.49%
+841.62K
+23.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.10M
2.44%
+311.13K
+11.15%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
WisdomTree US SmallCap Fund
0.11%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
Mehr Anzeigen
WisdomTree US SmallCap Fund
Anteil0.11%
iShares Micro-Cap ETF
Anteil0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.05%
Franklin US Small Cap Multifactor Index ETF
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.03%
Fidelity Enhanced Small Cap ETF
Anteil0.03%
iShares Russell 2000 Growth ETF
Anteil0.02%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.02%
Proshares Ultra Russell 2000
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
